miRNA Compositions and Methods for Treating Age-Related Macular Degeneration and Pathological Anigogenesis and Fibrosis in the Heart, Lung and Liver
Background
Tulane University is actively seeking commercial entities to further develop and commercialize a miRNA drug which can treat multiple disease targets.
Applications
Useful for treatment of multiple factors of Age-related Macular Degeneration. These targets have implications in other disease states including pathological angiogenesis and fibrosis of the heart, lung, and liver.
Current Work
This biologic has been tested with in vitro assays as well as in an in vivo mouse model of Choroidal Neovascularisation (CNV).
Inventors
Intellectual Property
Provisional US Application 62,822,503
Available For
Exclusive License in a Field
Non-exclusive License
Scientific Collaboration
